Detalhe da pesquisa
1.
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease.
Clin Infect Dis
; 76(3): e1186-e1194, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925555
2.
Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers.
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558286
3.
Dried Blood Spot Technique-Based Liquid Chromatography-Tandem Mass Spectrometry Method as a Simple Alternative for Benznidazole Pharmacokinetic Assessment.
Antimicrob Agents Chemother
; 62(12)2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30275095
4.
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.
Lancet Infect Dis
; 24(4): 395-403, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218194
5.
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Lancet Infect Dis
; 21(8): 1129-1140, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836161
6.
In vitro and in vivo experimental models for drug screening and development for Chagas disease.
Mem Inst Oswaldo Cruz
; 105(2): 233-8, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20428688
7.
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Mem. Inst. Oswaldo Cruz
; 105(2): 233-238, Mar. 2010. ilus
Artigo
em Inglês
| LILACS | ID: lil-544632
8.
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Artigo
em Inglês
| ARCA | ID: arc-5794